Page last updated: 2024-09-03

pramipexole and Depressive Disorder, Major

pramipexole has been researched along with Depressive Disorder, Major in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (40.00)29.6817
2010's8 (40.00)24.3611
2020's4 (20.00)2.80

Authors

AuthorsStudies
Attenburrow, MJ; Au-Yeung, SK; Bogacz, R; Browning, M; Chan, F; Cipriani, A; Cleare, A; Cowen, P; Edwards, C; Evans, J; Geddes, J; Griffiths, J; Harmer, CJ; Harrison, PJ; Kessler, D; Lewis, G; Rendell, J; Roberts, S; Shanyinde, M; Simon, J; Singh, I; Watson, S; Yu, LM1
Abi-Dargham, A; Ang, YS; Iosifescu, DV; McGrath, PJ; Pizzagalli, DA; Reinen, JM; Schneier, FR; Slifstein, M; Whitton, AE1
DiMario, K; Fedoroff, JP; Ly, T; Mihowich, T; Murphy, L1
Betro', S; de Filippis, R; Iommi, M; Tundo, A1
De Crescenzo, F; de Filippis, R; Tundo, A1
Franco-Chaves, JA; Luckenbaugh, DA; Mallinger, AG; Martinez, PE; Mateus, CF; Zarate, CA1
Arnulf, I; Brion, A; Launois, C; Leu-Semenescu, S1
Cusin, C; Fava, M; Iosifescu, DV; Iovieno, N; Nierenberg, AA; Perlis, RH; Rush, AJ1
Hara, C; Rocha, FL1
Diaz, SH; Dunklee, L; Escalona, R; Fawcett, J; Romo, P; Rush, AJ; Vukelich, J; Yarns, BC1
Letvinenko, IV; Mogil'naia, VI; Odinak, MM1
Nibuya, M; Nomura, S; Takahashi, T1
Boku, S; Inoue, T; Kitaichi, Y; Koyama, T; Masui, T; Nakagawa, S; Nakato, Y; Suzuki, K; Tanaka, T; Usui, R1
Abelli, M; Bassi, A; Battistini, G; Cassano, GB; Cassano, P; Dell'Osso, L; Gemignani, A; Houck, PR; Lattanzi, L; Pini, S; Rucci, P1
Burdick, KE; Endick, CJ; Goldberg, JF1
Battistini, G; Cassano, GB; Cassano, P; Gemignani, A; Lattanzi, L; Navari, S; Soldani, F1
Frank, B; Gupta, S; Vincent, JL1
Antonini, A; Barone, P; Bracco, F; Marconi, R; Morgante, L; Musch, B; Scarzella, L; Zappia, M1
Breen, JA; DeBattista, C; Schatzberg, AF; Solvason, HB1
Corrigan, MH; Denahan, AQ; Evans, DL; Ragual, RJ; Wright, CE1

Reviews

1 review(s) available for pramipexole and Depressive Disorder, Major

ArticleYear
Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta-analysis.
    Acta psychiatrica Scandinavica, 2019, Volume: 140, Issue:2

    Topics: Adolescent; Adult; Aged; Bipolar Disorder; Case-Control Studies; Depressive Disorder, Major; Dopamine Agonists; Female; Humans; Male; Middle Aged; Observational Studies as Topic; Placebos; Pramipexole; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult

2019

Trials

10 trial(s) available for pramipexole and Depressive Disorder, Major

ArticleYear
PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression.
    Evidence-based mental health, 2022, Volume: 25, Issue:2

    Topics: Antidepressive Agents; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Humans; Pramipexole; Quality of Life; Randomized Controlled Trials as Topic

2022
Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study.
    Journal of affective disorders, 2013, Volume: 149, Issue:1-3

    Topics: Adult; Antidepressive Agents; Benzothiazoles; Citalopram; Depressive Disorder, Major; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Pramipexole; Selective Serotonin Reuptake Inhibitors

2013
A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.
    The Journal of clinical psychiatry, 2013, Volume: 74, Issue:7

    Topics: Adult; Aged; Antidepressive Agents; Benzothiazoles; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pramipexole; Psychiatric Status Rating Scales; Remission Induction; Treatment Outcome

2013
[Pain and depression in Parkinson's disease: new therapeutic possibilities of pramipexole].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2008, Volume: 108, Issue:11

    Topics: Aged; Amantadine; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Movement Disorders; Pain; Pain Measurement; Parkinson Disease; Pramipexole; Severity of Illness Index

2008
Pramipexole for stage 2 treatment-resistant major depression: an open study.
    Progress in neuro-psychopharmacology & biological psychiatry, 2010, Dec-01, Volume: 34, Issue:8

    Topics: Adult; Benzothiazoles; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Pilot Projects; Pramipexole; Prospective Studies; Treatment Outcome

2010
Pramipexole in treatment-resistant depression: a 16-week naturalistic study.
    Bipolar disorders, 2002, Volume: 4, Issue:5

    Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Benzothiazoles; Combined Modality Therapy; Depressive Disorder, Major; Dopamine Agonists; Drug Administration Schedule; Drug Resistance, Multiple; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Pramipexole; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Thiazoles

2002
Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.
    The American journal of psychiatry, 2004, Volume: 161, Issue:3

    Topics: Adult; Ambulatory Care; Anticonvulsants; Antimanic Agents; Benzothiazoles; Bipolar Disorder; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Assessment; Pilot Projects; Pramipexole; Thiazoles

2004
Pramipexole in treatment-resistant depression: an extended follow-up.
    Depression and anxiety, 2004, Volume: 20, Issue:3

    Topics: Acute Disease; Adult; Aged; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pramipexole; Prospective Studies; Surveys and Questionnaires; Thiazoles; Treatment Outcome

2004
Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study.
    Journal of neurology, 2006, Volume: 253, Issue:5

    Topics: Aged; Analysis of Variance; Antidepressive Agents; Antiparkinson Agents; Benzothiazoles; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Psychiatric Status Rating Scales; Sertraline; Single-Blind Method

2006
Comparison of pramipexole, fluoxetine, and placebo in patients with major depression.
    Depression and anxiety, 2000, Volume: 11, Issue:2

    Topics: Adult; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Assessment; Pramipexole; Selective Serotonin Reuptake Inhibitors; Thiazoles

2000

Other Studies

9 other study(ies) available for pramipexole and Depressive Disorder, Major

ArticleYear
Baseline reward processing and ventrostriatal dopamine function are associated with pramipexole response in depression.
    Brain : a journal of neurology, 2020, 02-01, Volume: 143, Issue:2

    Topics: Adult; Depression; Depressive Disorder, Major; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Learning; Male; Middle Aged; Pramipexole; Reward

2020
Treatment of Pramipexole-Induced Problematic Sexual Behaviors.
    The primary care companion for CNS disorders, 2021, Feb-18, Volume: 23, Issue:1

    Topics: Adult; Compulsive Behavior; Depressive Disorder, Major; Dopamine Agonists; Humans; Male; Pramipexole; Restless Legs Syndrome

2021
Efficacy and safety of 24-week pramipexole augmentation in patients with treatment resistant depression. A retrospective cohort study.
    Progress in neuro-psychopharmacology & biological psychiatry, 2022, 01-10, Volume: 112

    Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Brief Psychiatric Rating Scale; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Off-Label Use; Pramipexole; Retrospective Studies; Treatment Outcome

2022
Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders.
    Sleep medicine, 2013, Volume: 14, Issue:7

    Topics: Aged, 80 and over; Benzothiazoles; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Substance Withdrawal Syndrome

2013
Compulsive Masturbation With Pramipexole for Antidepressant Augmentation in Major Depression: A Case Report.
    Journal of clinical psychopharmacology, 2015, Volume: 35, Issue:4

    Topics: Antidepressive Agents; Benzothiazoles; Compulsive Behavior; Depressive Disorder, Major; Dopamine Agonists; Female; Humans; Masturbation; Middle Aged; Pramipexole

2015
Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression.
    The American journal of psychiatry, 2016, Feb-01, Volume: 173, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Benzothiazoles; Bipolar Disorder; Bupropion; Cohort Studies; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nortriptyline; Pramipexole; Retrospective Studies; Treatment Outcome; Venlafaxine Hydrochloride

2016
Delusion of Cotard's syndrome successfully treated with a dopamine agonist.
    The Journal of neuropsychiatry and clinical neurosciences, 2010,Spring, Volume: 22, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Anxiety; Benzothiazoles; Delusions; Depressive Disorder, Major; Dopamine Agonists; Female; Follow-Up Studies; Humans; Middle Aged; Paroxetine; Pramipexole; Recurrence; Syndrome; Treatment Outcome

2010
Pramipexole: augmentation in the treatment of depressive symptoms.
    CNS spectrums, 2006, Volume: 11, Issue:3

    Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzothiazoles; Bipolar Disorder; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Pramipexole; Somatoform Disorders; Thiazoles

2006
Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2

    Topics: Benzothiazoles; Chronic Disease; Depressive Disorder, Major; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Middle Aged; Pramipexole; Selective Serotonin Reuptake Inhibitors; Sertraline; Thiazoles

2000